Katherine A. High, M.D.

Katherine A. High, M.D.

INDEPENDENT DIRECTORatIncyte· In proxies 2023–2025

Katherine A. High, M.D. sits on 3 public boards.

Boards2

  • IncyteDirector · 5 yr on the boardIndependentScience and Technology—Paid as an executive
  • CRISPR Therapeutics AGDirector · 4 yr on the boardIndependentDirectors and Executive, Nominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. IncytePublic company · 3 yr
    • INDEPENDENT DIRECTOR2023 – Present · 3 yrStock in role +47%
  2. CRISPR Therapeutics AGPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?